A detailed history of Signature Wealth Management Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Signature Wealth Management Group holds 24,947 shares of ABBV stock, worth $4.7 Million. This represents 2.03% of its overall portfolio holdings.

Number of Shares
24,947
Previous 26,466 5.74%
Holding current value
$4.7 Million
Previous $4.54 Million 8.53%
% of portfolio
2.03%
Previous 2.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $248,872 - $302,782
-1,519 Reduced 5.74%
24,947 $4.93 Million
Q2 2024

Jul 15, 2024

SELL
$154.79 - $180.76 $121,355 - $141,715
-784 Reduced 2.88%
26,466 $4.54 Million
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $187,788 - $213,967
-1,175 Reduced 4.13%
27,250 $4.96 Million
Q4 2023

Jan 09, 2024

SELL
$137.6 - $154.97 $73,753 - $83,063
-536 Reduced 1.85%
28,425 $4.41 Million
Q2 2023

Jul 10, 2023

BUY
$132.51 - $164.9 $64,267 - $79,976
485 Added 1.7%
28,961 $3.9 Million
Q1 2023

Apr 14, 2023

SELL
$144.61 - $166.54 $48,155 - $55,457
-333 Reduced 1.16%
28,476 $4.54 Million
Q4 2022

Jan 10, 2023

SELL
$138.31 - $165.87 $132,086 - $158,405
-955 Reduced 3.21%
28,809 $0
Q3 2022

Nov 02, 2022

SELL
$134.21 - $153.93 $262,514 - $301,087
-1,956 Reduced 6.17%
29,764 $4 Million
Q2 2022

Jul 14, 2022

SELL
$137.62 - $174.96 $510,157 - $648,576
-3,707 Reduced 10.46%
31,720 $4.86 Million
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $79,847 - $99,068
-605 Reduced 1.68%
35,427 $5.74 Million
Q4 2021

Jan 31, 2022

SELL
$107.43 - $135.93 $90,348 - $114,317
-841 Reduced 2.28%
36,032 $4.88 Million
Q3 2021

Oct 26, 2021

SELL
$106.4 - $120.78 $30,962 - $35,146
-291 Reduced 0.78%
36,873 $3.98 Million
Q2 2021

Jul 16, 2021

SELL
$105.21 - $117.21 $17,780 - $19,808
-169 Reduced 0.45%
37,164 $4.19 Million
Q1 2021

Apr 15, 2021

SELL
$102.3 - $112.62 $31,099 - $34,236
-304 Reduced 0.81%
37,333 $4.04 Million
Q4 2020

Jan 15, 2021

BUY
$80.49 - $108.67 $80,248 - $108,343
997 Added 2.72%
37,637 $4.03 Million
Q3 2020

Oct 22, 2020

BUY
$85.91 - $100.83 $257 - $302
3 Added 0.01%
36,640 $3.21 Million
Q2 2020

Jul 20, 2020

SELL
$73.37 - $98.18 $9,758 - $13,057
-133 Reduced 0.36%
36,637 $3.6 Million
Q1 2020

May 26, 2020

SELL
$64.5 - $97.79 $3,741 - $5,671
-58 Reduced 0.16%
36,770 $2.8 Million
Q4 2019

Jan 15, 2020

BUY
$72.13 - $90.25 $60,805 - $76,080
843 Added 2.34%
36,828 $3.26 Million
Q3 2019

Oct 21, 2019

SELL
$62.98 - $75.72 $314 - $378
-5 Reduced 0.01%
35,985 $2.73 Million
Q2 2019

Jul 08, 2019

BUY
$65.7 - $83.98 $48,486 - $61,977
738 Added 2.09%
35,990 $2.63 Million
Q1 2019

Apr 17, 2019

BUY
$77.14 - $90.79 $241,602 - $284,354
3,132 Added 9.75%
35,252 $2.84 Million
Q4 2018

Feb 11, 2019

BUY
$77.85 - $96.01 $40,559 - $50,021
521 Added 1.65%
32,120 $2.96 Million
Q3 2018

Oct 30, 2018

BUY
$88.91 - $98.84 $159,593 - $177,417
1,795 Added 6.02%
31,599 $2.57 Million
Q2 2018

Jul 17, 2018

BUY
$89.78 - $106.23 $45,159 - $53,433
503 Added 1.72%
29,804 $2.76 Million
Q1 2018

Apr 12, 2018

SELL
$92.01 - $123.21 $1.22 Million - $1.64 Million
-13,297 Reduced 31.22%
29,301 $2.77 Million
Q4 2017

Apr 11, 2018

BUY
$89.56 - $98.21 $3.82 Million - $4.18 Million
42,598
42,598 $4.12 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $333B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Signature Wealth Management Group Portfolio

Follow Signature Wealth Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Wealth Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Signature Wealth Management Group with notifications on news.